CN107243043A - A kind of Chinese medicine treated diabetes and control its complication to occur - Google Patents
A kind of Chinese medicine treated diabetes and control its complication to occur Download PDFInfo
- Publication number
- CN107243043A CN107243043A CN201710704155.7A CN201710704155A CN107243043A CN 107243043 A CN107243043 A CN 107243043A CN 201710704155 A CN201710704155 A CN 201710704155A CN 107243043 A CN107243043 A CN 107243043A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine
- complication
- diabetes
- control
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Abstract
The invention discloses a kind of Chinese medicine treated diabetes and control its complication to occur, it is related to a kind of Chinese medicine, and in particular to a kind of Chinese medicine for treating diabetes.Include the raw material of following ratio of weight and number：American Ginseng 33 37；The Radix Astragali 142 158；Chinese yam 95 105；Dark plum 76 84；Gorgon fruit 67 73；Sea-buckthorn 100 110；The fruit of Chinese magnoliavine 52 58；Spina date seed 33 37；Pumpkin powder 95 105；The root of kudzu vine 71 79；Radix glycyrrhizae 33 37；Chromium gluconate 0.12 0.124.The composition that the present invention solves existing treatment Chinese medicine for treating diabetes is more, is not suitable for being used for a long time.The problem of above-mentioned patent controls the DeGrain of diabetic complication in addition.
Description
Technical field
The present invention relates to a kind of Chinese medicine, and in particular to a kind of Chinese medicine for treating diabetes.
Background technology
Diabetes are one group of metabolic diseases being characterized with hyperglycaemia.Hyperglycaemia be due to then defect of insulin secretion or
Its biological agent is damaged, or both have concurrently and cause.Long-standing hyperglycaemia during diabetes, cause various tissues, particularly eye,
Kidney, heart, blood vessel, the chronic lesion of nerve, dysfunction.The cause of disease of diabetes is complicated, and final conclusion is there is no so far, is led to
Often think with inherent cause and environmental factor and interaction complicated therebetween is relevant.Diabetes classification is insulin
Dependent diabetes (I type) and Non-Insulin Dependent Diabetes Mellitus (II type).
The chronic complicating diseases treatment of diabetes is also major issue, because traditional treating diabetes lay stress on blood
On sugar, the change of blood pressure, therefore diabetic complication never has and is controlled effectively.The pathology of the complication of diabetes is former
Cause, actual is all the blood vessel scleratheroma lesion of correspondence organ, and simply kidney, eye, pedopathy are brain, heart based on tiny blood vessels
Disease is that based on medium vessels, but its pathologic basis is all atherosclerosis.And cause the immediate cause of artery sclerosis not lie in
The height of blood glucose, and the number of blood fat, especially HDL HDL be（Hereinafter referred to as HDL）Number and oxidation
Low-density lipoprotein Ox-LDL（Hereinafter referred to as Ox-LDL）Situation.Long-term blood glucose increases, and big blood vessel, capilary are damaged and jeopardized
The heart, brain, kidney, peripheral nerve, eyes, foot etc..
Chinese patent literature CN103495020B discloses a kind of Chinese medicine for treating diabetes, and it is by following weight proportion
Material medicine component composition：Dried rhizome of rehmannia 15-20g, radix scrophulariae 20-30g, wind-weed 10-15g, root of kudzu vine 20-30g, pollen 10-15g,
Asparagus fern 15-20g, tuber of dwarf lilyturf 15-20g, Radix Astragali 20-30g, Chinese yam 10-15g, coptis 6-9g, ginseng 6-9g, rhizoma atractylodis 10-15g, radix glycyrrhizae
6-9g.The invention Chinese medicine has the advantages that good effect, cure rate are high, had no toxic side effect.
Chinese patent literature CN102274471B discloses a kind of pharmaceutical composition for treating diabetes.The invention includes：
16 parts of lucid asparagus；30 parts of radix scutellariae；16 parts of radix scrophulariae；30 parts of the Radix Astragali；16 parts of American Ginseng；30 parts of root of Chinese trichosanthes；16 parts of the fruit of Chinese magnoliavine；
12 parts of Radix Angelicae Sinensis；30 parts of Semen Cuscutae；See that blood is blue or green 10 parts；45 parts of sealwort；16 parts of cloves；30 parts of Chinese yam；16 parts of the root bark of tree peony；In vain
16 parts of art；30 parts of the dried rhizome of rehmannia；20 parts of radix pseudostellariae；30 parts of the tuber of dwarf lilyturf；20 parts of the wind-weed；16 parts of Poria cocos；16 parts of the fruit of Chinese wolfberry；Dogwood fruit
30 parts；35 parts of Ramulus euonymi；30 parts of gypsum；20 parts of rhizoma alismatis；15 parts of mast；30 parts of Radix Codonopsis；20 parts of turmeric；Caulis lonicerae
30 parts；30 parts of pipewort；30 parts of the coptis；9 parts of honey-fried licorice root；12 parts of rheum officinale；30 parts of radix polygonati officinalis；30 parts of the root of kudzu vine；Ligusticum wallichii 16
Part；Wherein, radix scutellariae, radix scrophulariae, the root bark of tree peony, the dried rhizome of rehmannia, the wind-weed, Radix Codonopsis and the coptis are externally applied drug, and remaining is medicine for oral administration.The drug regimen
Thing can effectively treat I-IV patients with type Ⅰ DM and its complication and hypertension, high fat of blood, hyperglycaemia.
Above-mentioned two patent Chinese medicinal ingredients are more, are not suitable for being used for a long time.Above-mentioned patent controls diabetic complication in addition
DeGrain.
The content of the invention
The present invention provides a kind of Chinese medicine treated diabetes and control its complication to occur, and the present invention solves existing treatment
The composition of Chinese medicine for treating diabetes is more, is not suitable for being used for a long time；And the DeGrain of above-mentioned patent control diabetic complication
Problem.
To solve the above problems, the present invention is adopted the following technical scheme that：One kind treats diabetes and controls its complication hair
Raw Chinese medicine, includes the raw material of following ratio of weight and number：American Ginseng 33-37；Radix Astragali 142-158；Chinese yam 95-105；Dark plum 76-
84；Gorgon fruit 67-73；Sea-buckthorn 100-110；Fruit of Chinese magnoliavine 52-58；Spina date seed 33-37；Pumpkin powder 95-105；Root of kudzu vine 71-79；Radix glycyrrhizae
33-37；Chromium gluconate 0.12-0.124.
Its preparation process is：（One）By said medicine broken wall；（Two）Heat filling is carried out to medicine and extracts concentration；（Three）Will be dense
Medicine, which is dried, after contracting dusts.
Its preparation process（One）, medicine broken wall uses wall-breaking machine rotating speed for 40000-45000 revs/min；Wall-breaking machine is each
The medicine of 0.4-1 kilograms of processing, broken time is 0.1-2 minutes.
Its preparation process（Two）Medicine carries out heat filling extraction concentration process：
（1）Medicinal material is put into extractor, the water of 5-10 times of Chinese medicine weight is added；
（2）After extract solution is heated into boiling 20--30 minutes, concentration tank is pumped into by 1/3rd extract solution；Make inspissated juice
Temperature is maintained at 80 DEG C or so, and vacuum is maintained at -0.05 and arrives -0.08MPA, is concentrated to paste.
Its preparation process（Three）Dry to dust and use vacuum rake dryer, pharmaceutical drying heating-up temperature is 80-99 DEG C.
The Chinese medicine preparation of the present invention is using the Radix Astragali, Chinese yam as monarch：Wherein the Radix Astragali is sweet, slightly warm in nature, can tonifying middle-Jiao and Qi.Chinese yam taste
It is sweet mild-natured, can kidney tonifying Yiyang, and can strengthening spleen, tonifying kidney；Using American Ginseng as ministerial drug, monarch drug in a prescription can be strengthened and reinforce the kidney taste by being shared with pumpkin powder
The moon, the work(invigorated the spleen and benefited qi；Sea-buckthorn can improve lipids contents and ratio, alleviate sugar metabolism levels；Spina date seed convergence gas is cloudy；The fruit of Chinese magnoliavine
Mitigate beta Cell of islet damage, increase its number；Dark plum energy insulin secretion accelerating, it is hypoglycemic, stimulate circulation, improve glycosuria
Sick pruritis；Gorgon fruit and radix glycyrrhizae can promote to absorb.It is altogether adjuvant collectively for diabetes patient's glucose -lipid metabolism disorder mechanism.
Above all medicines share, plays mediation the five internal organs altogether, and kidney tonifying enriching yin, strengthening the spleen and replenishing qi, the work(promoted the production of body fluid to quench thirst cures mainly spleen kidney deficiency, gas the moon two
Empty quenches one's thirst.
Present invention treatment diabetes and the Chinese medicine for controlling its complication to occur are broken by Chinese medicine using modern biotechnology
Wall, circumfluence distillation concentration, finally drying are dusted, so that the active component in pharmaceutical formulation is retained very well, improved
Therapeutic effect.Present invention treatment diabetes and the Chinese medicine for controlling its complication to occur can be free from side effects with long-term taking, be treated
Diabetes and complication work well, and cure rate is high.
Embodiment
The present invention is described in detail with optimal embodiment below.
A kind of Chinese medicine treated diabetes and control its complication to occur, includes the raw material of following ratio of weight and number：The West
Join 33-37；Radix Astragali 142-158；Chinese yam 95-105；Dark plum 76-84；Gorgon fruit 67-73；Sea-buckthorn 100-110；Fruit of Chinese magnoliavine 52-58；Acid
Jujube kernel 33-37；Pumpkin powder 95-105；Root of kudzu vine 71-79；Radix glycyrrhizae 33-37；Chromium gluconate 0.12-0.124.
Its preparation process is：（One）By said medicine broken wall；（Two）Heat filling is carried out to medicine and extracts concentration；（Three）Will be dense
Medicine, which is dried, after contracting dusts.
Its preparation process（One）, medicine broken wall uses wall-breaking machine rotating speed for 40000-45000 revs/min；Wall-breaking machine is each
The medicine of 0.4-1 kilograms of processing, broken time is 0.5-5 minutes.
Its preparation process（Two）Medicine carries out heat filling extraction concentration process：
（1）Medicinal material is put into extractor, the water of 5-10 times of Chinese medicine weight is added；
（2）After extract solution is heated into boiling 20--30 minutes, concentration tank is pumped into by 1/3rd extract solution；Make inspissated juice
Temperature is maintained at 80 DEG C or so, and vacuum is maintained at -0.05 and arrives -0.08MPA, and the indirect steam produced during concentration passes through condenser
With cooler become condensate liquid be back to extractor do novel solvent add medicine in, novel solvent from top to bottom pass through medicinal material layer to extraction
Soluble component in pot bottom, medicinal material is dissolved in extractor internal solvent, and extract solution is pumped into concentration tank through suction filtering tube, and concentration is produced
Indirect steam deliver to extractor again and do novel solvent, novel solvent refluxing extraction is formed, until complete dissolution (extracting liquid colourless) is dense
Contracting proceeds, until being condensed into the proportion ointment of needs；Colourless liquid in extractor can be multiplexed next time, if organic solvent
Extract, then first add suitable quantity of water, open straight system and chuck hot water, recycling design.
Its preparation process（Three）Dry to dust and use vacuum rake dryer, medicine is added from middle above housing,
Under the stirring of the rake teeth constantly rotated, when material is contacted with housing wall, surface is constantly updated, and is dried medicine heating-up temperature and is
80-99 DEG C, medicine is by steam（Or hot water, conduction oil）Indirectly heat, and the moisture of Chinese medicine is vaporized, the moisture of vaporization is by true
Empty pump is taken away in time.
Dried material is by the indirectly heat of heat carrier, and breaking-wall cell is a kind of superfine powder process technology.If Chinese medicine
Crushed using usual manner, its single particle is often made up of several or dozens of cell, and the sporoderm-broken rate of cell is extremely low.Chinese medicine
Breaking-wall cell ultramicro grinding process technology can fully discharge medicinal material active ingredient.After breaking-wall cell, intracellular water
Part oil content is moved out, and particulate surface is showed semi-moist state, stable particle cluster can be formed between particle and particle, each
Particle cluster all includes the traditional Chinese medicine ingredients of same ratio.The physical arrangement of the particle cluster is with each composition HLB value in component（It is hydrophilic, parent
Oily equilibrium valve）, ductility, brokenness, various combination and the different interactions such as proportion and it is different.This structure is conducive to people
Absorption and utilization of the body to Chinese medicine.The fat-soluble enhancing of Chinese medicine, readily passes through adipose membrane, and the blood concentration in human body can be put forward rapidly,
Reach the purpose for curing disease.
The present invention Chinese medicine instructions of taking be：Every pair of 30-40 grams of dose, divides 3 times and is taken with warm water by daily 1 pair, the early, noon
Before meals, late one after each meal.It is within 1 month a small course for the treatment of, is within 3 months a big course for the treatment of.
Share 30 people and take this medicine, wherein 15 people are IDDM, complication is：Dry, four limbs are aching and limp, heart and brain blood
Pipe disease, gastrointestinal disease；15 people are type II diabetes, and complication is：Kidney trouble, DPN, illness in eye etc..
The people of first stage 30 takes the small course for the treatment of of medicine one of the present invention respectively：30 people's drys, the constitutional symptom such as four limbs are aching and limp is bright
Aobvious to improve, blood glucose, glucose in urine start to fall after rise；The four limbs of type i diabetes people are aching and limp, and cardiovascular and cerebrovascular disease, gastrointestinal disease all take a turn for the better；
Type II diabetes, complication is：Kidney trouble, DPN, Ocular indications have 14 people improvement, and 1 people does not have effect.This stage takes
Obvious effective rate is 96.7% after medicine.
Above-mentioned 30 people of second stage continues to take the big course for the treatment of of medicine one of the present invention：30 people's blood glucose, glucose in urine are decreased obviously, many
Urine, hunger and insomnia are clearly better, and the people of syndrome 30 all mitigates；
Phase III above-mentioned 30 people continues to take the big course for the treatment of of medicine one of the present invention：Blood glucose, glucose in urine tend to be normal, mild complications
It is clearly better, tuberculosis, Peripheral neuropathy and skin infection, urinary tract infections are improved in varying degrees；
Above-mentioned 30 people of fourth stage continues to take the big course for the treatment of of medicine one of the present invention：Blood glucose, glucose in urine keep normal condition, and severe is simultaneously
Send out disease such as cardiovascular disease, nephrosis, PVR etc. and good favourable turn occur.Last entirety obtains control close to normally.
By the contrast in aforementioned four stage, Chinese medicine of the present invention is mainly for blood glucose is unstable, diabetes complication（The heart
Cranial vascular disease, kidney trouble, gastrointestinal disease, DPN, illness in eye etc.）, take this formula one month, above symptom can be obtained
To preferable improvement, adhere to taking, blood glucose can obtain stabilization, and no longer fluctuated, complication can disappear.Effective percentage reaches
96.7%.This product patient of 3 years is taken, the generation without any diabetic complication is not only high without the patient taken
Blood glucose is fluctuated, and has complication more.
Finally it should be noted that：Obviously, above-described embodiment is only intended to clearly illustrate example of the present invention, and simultaneously
The non-restriction to embodiment.For those of ordinary skill in the field, it can also do on the basis of the above description
Go out other various forms of changes or variation.There is no necessity and possibility to exhaust all the enbodiments.And thus drawn
Among the obvious changes or variations that Shen goes out is still in protection scope of the present invention.
Claims (5)
1. a kind of Chinese medicine treated diabetes and control its complication to occur, it is characterised in that including following ratio of weight and number
Raw material：American Ginseng 33-37；Radix Astragali 142-158；Chinese yam 95-105；Dark plum 76-84；Gorgon fruit 67-73；Sea-buckthorn 100-110；The five tastes
Sub- 52-58；Spina date seed 33-37；Pumpkin powder 95-105；Root of kudzu vine 71-79；Radix glycyrrhizae 33-37；Chromium gluconate 0.12-0.124.
2. a kind of as claimed in claim 1 treat diabetes and the Chinese medicine of control its complication generation, it is characterised in that it is prepared
Step is：（One）By said medicine broken wall；（Two）Heat filling is carried out to medicine and extracts concentration；（Three）Medicine is done after concentrating
It is dry to dust.
3. a kind of as claimed in claim 2 treat diabetes and the Chinese medicine of control its complication generation, it is characterised in that it is prepared
Step（One）, medicine broken wall uses wall-breaking machine rotating speed for 40000-45000 revs/min；Wall-breaking machine processes 0.4-1 kilograms every time
Medicine, broken time is 0.1-2 minutes.
4. a kind of as claimed in claim 2 treat diabetes and the Chinese medicine of control its complication generation, it is characterised in that it is prepared
Step（Two）Medicine carries out heat filling extraction concentration process：
（1）Medicinal material is put into extractor, the water of 5-10 times of Chinese medicine weight is added；
（2）After extract solution is heated into boiling 20--30 minutes, concentration tank is pumped into by 1/3rd extract solution；Make inspissated juice
Temperature is maintained at 80 DEG C or so, and vacuum is maintained at -0.05 and arrives -0.08MPA, is concentrated to paste.
5. a kind of as claimed in claim 2 treat diabetes and the Chinese medicine of control its complication generation, it is characterised in that it is prepared
Step（Three）Dry to dust and use vacuum rake dryer, pharmaceutical drying heating-up temperature is 80-99 DEG C.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710704155.7A CN107243043A (en) | 2017-08-17 | 2017-08-17 | A kind of Chinese medicine treated diabetes and control its complication to occur |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710704155.7A CN107243043A (en) | 2017-08-17 | 2017-08-17 | A kind of Chinese medicine treated diabetes and control its complication to occur |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107243043A true CN107243043A (en) | 2017-10-13 |
Family
ID=60012870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710704155.7A Pending CN107243043A (en) | 2017-08-17 | 2017-08-17 | A kind of Chinese medicine treated diabetes and control its complication to occur |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107243043A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110613771A (en) * | 2019-11-05 | 2019-12-27 | 任国旺 | Manufacturing process of eye patch for relieving dry eyes, unsmooth eyes and asthenopia |
| CN113384644A (en) * | 2021-07-29 | 2021-09-14 | 吴洪宇 | A Chinese medicinal composition and its preparation method |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002009693A1 (en) * | 2000-08-02 | 2002-02-07 | Pharmanutrients | Method and compositions for prevention and/or treatment of diabetes and glucose modulation |
| US20050079234A1 (en) * | 2003-08-27 | 2005-04-14 | Chiang Yang Chi | Compositions comprising herbs and method for immunomodulation |
-
2017
- 2017-08-17 CN CN201710704155.7A patent/CN107243043A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002009693A1 (en) * | 2000-08-02 | 2002-02-07 | Pharmanutrients | Method and compositions for prevention and/or treatment of diabetes and glucose modulation |
| US20050079234A1 (en) * | 2003-08-27 | 2005-04-14 | Chiang Yang Chi | Compositions comprising herbs and method for immunomodulation |
Non-Patent Citations (3)
| Title |
|---|
| 劳其文等: "《新编教师健康手册》", 31 October 2008, 济南出版社 * |
| 文香兰等: "葡萄糖酸铬对糖尿病小鼠血糖水平的影响", 《微量元素与健康研究》 * |
| 高永喜等: "山药参芪丸治疗糖尿病疗效观察", 《人民军医》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110613771A (en) * | 2019-11-05 | 2019-12-27 | 任国旺 | Manufacturing process of eye patch for relieving dry eyes, unsmooth eyes and asthenopia |
| CN113384644A (en) * | 2021-07-29 | 2021-09-14 | 吴洪宇 | A Chinese medicinal composition and its preparation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103750107B (en) | Health-care product with blood glucose reducing function | |
| CN110051782A (en) | Ginseng extract and its preparation process | |
| CN101690789B (en) | Chinese medicinal preparation for treating diabetes | |
| CN102160884A (en) | Chinese medicinal preparation for treating acute period vital myocarditis | |
| CN107243043A (en) | A kind of Chinese medicine treated diabetes and control its complication to occur | |
| CN108186890A (en) | A kind of pharmaceutical composition for treating diabetes | |
| CN104324222A (en) | Traditional Chinese medicine preparation for treating Qi and Yin deficiency type dry eye syndromes | |
| CN103735843A (en) | Medicine composition for treating diabetes | |
| CN108245583A (en) | It is a kind of have the function of clearing damp invigorating the spleen, lowering blood-fat and reducing weight complex polysaccharide and preparation method and application | |
| CN103725587A (en) | Sealwort and hawthorn vinegar and production method thereof | |
| CN1879783A (en) | A medicine for treating diabetes | |
| CN105902867B (en) | A herbal composition for reducing hypertension, hyperglycemia and hyperlipidemia, and its preparation method | |
| CN110882362A (en) | Traditional Chinese medicine food therapy product for conditioning diabetes and preparation method thereof | |
| CN1238944A (en) | Process for preparing powdered bath lotion from liquid one of natural plant | |
| CN104740345B (en) | Treat Chinese medicine composition of diabetes and preparation method thereof | |
| CN107648397A (en) | It is a kind of to be used to treat Chinese medicine composition of liver-kidney yin deficiency and its preparation method and application | |
| CN1261147C (en) | Chinese medicinal preparation for treating climacteric metancholia of qi and blood deficiency type and preparing process thereof | |
| CN103599259A (en) | Dai medicine extract with hypoglycemic effect, preparation and application thereof | |
| CN108392583A (en) | A kind of Chinese medicine preparation for treating diabetic nephropathy | |
| CN103877374B (en) | A kind of for Chinese medicine treating diabetes and preparation method thereof | |
| CN106581425A (en) | Pharmaceutical composition for treating | |
| CN116570679A (en) | Blood sugar reducing and heart soothing formula applied to diabetic myocardial injury | |
| CN105106817A (en) | Yao medicine compound broadleaf globethistle inflorescence tablet for treating diabetes and preparation method thereof | |
| CN105521262A (en) | Healthcare food capable of assisting in blood sugar decrease and preparation method of healthcare food capable of assisting in blood sugar decrease | |
| CN105213777A (en) | A kind of Chinese medicine composition is for the preparation of the purposes in treatment medicine for treating diabetic nephropathy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171013 |
|
| RJ01 | Rejection of invention patent application after publication |